by Jordana Choucair | Jun 2, 2022 | Life Sciences
Pfizer announced that the Food and Drug Administration (FDA) accepted its application for a three-dose COVID-19 vaccine in children aged 6 months to under 5 years old. In February, the FDA asked Pfizer-BioNTech to submit a request for emergency use authorization (EUA)...
by Jordana Choucair | Jun 2, 2022 | Life Sciences
USC’s Schaeffer Center for Health Policy and Economics released a report examining how pharmacy benefit managers’ (PBMs) tactics such as spread pricing and copay clawbacks are driving up consumers’ costs for generic drugs. For example, Medicare Part D standalone drug...
by Jordana Choucair | Jun 2, 2022 | M&A
According to an Axios report, Optum has purchased Healthcare Associates of Texas (HCAT) from Webster Equity Partners. HCAT has a large footprint in the Dallas-Fort Worth metropolitan area and has also invested heavily in value-based care, both of which make it an...
by Jordana Choucair | Jun 2, 2022 | M&A
Value-based care provider CareMax announced plans to acquire Steward Health Care System’s Medicare value-based care business. The roughly $135 million deal would more than quintuple CareMax’s current number of covered seniors. The company currently covers roughly...
by Jordana Choucair | Jun 2, 2022 | M&A
Two Pennsylvania health systems – Butler Health System and Excela Health – have signed a letter of intent to merge. If finalized, the new five-hospital system would generate more than $1 billion in revenue and be the third largest in Western Pennsylvania based on...
by Jordana Choucair | Jun 2, 2022 | Payers
A new Kaiser Family Foundation analysis found that private insurance companies are expecting to pay out $1 billion in rebates to consumers this fall under the Affordable Care Act (ACA) Medical Loss Ratio (MLR) provision. Individual market insurers are expected to pay...
Recent Comments